FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:158-165 July 10, 2008 Number 2 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

SUMMARY

Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide–cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.

Source Information

From the Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City (D.M.H-Z., L.V.Z.); and the Cardiovascular Genetics Laboratory, Departments of Internal Medicine (M.L.K., D.D., K.J.H., J.D.B., T.M.O.) and Pediatric and Adolescent Medicine (T.M.O.), the Cardiorenal Research Laboratory, Departments of Physiology and Internal Medicine (D.M.H., J.C.B.), and the Department of Health Sciences Research (M.A.) — all at the College of Medicine, Mayo Clinic, Rochester, MN.

Address reprint requests to Dr. Olson at Mayo Clinic, 200 First St. SW, Rochester, MN 55905, or at olson.timothy{at}mayo.edu.

Full Text of this Article

This article has been cited by other articles:

• Patton, K. K., Ellinor, P. T., Heckbert, S. R., Christenson, R. H., DeFilippi, C., Gottdiener, J. S., Kronmal, R. A. (2009). N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study. Circulation 120: 1768-1774 [Abstract] [Full Text]  
• Campuzano, O., Brugada, R. (2009). Genetics of familial atrial fibrillation. Europace 11: 1267-1271 [Abstract] [Full Text]  
• McKie, P. M., Cataliotti, A., Huntley, B. K., Martin, F. L., Olson, T. M., Burnett, J. C. Jr (2009). A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.. J Am Coll Cardiol 54: 1024-1032 [Abstract] [Full Text]  
• de Bold, A. J. (2009). Cardiac natriuretic peptides: gaining further insights into structure-function relationships.. J Am Coll Cardiol 54: 1033-1034 [Full Text]  
• Dickey, D. M., Yoder, A. R., Potter, L. R. (2009). A Familial Mutation Renders Atrial Natriuretic Peptide Resistant to Proteolytic Degradation. J. Biol. Chem. 284: 19196-19202 [Abstract] [Full Text]  
• Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H.-C., Goette, A., Israel, C. W., Kuck, K.-H., Lip, G. Y.H., Nattel, S., Page, R. L., Ravens, U., Schotten, U., Steinbeck, G., Vardas, P., Waldo, A., Wegscheider, K., Willems, S., Breithardt, G. (2009). Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace 11: 860-885 [Full Text]  
• Zhou, Y., Jiang, J., Cui, Y., Wu, Q. (2009). Corin, atrial natriuretic peptide and hypertension. Nephrol Dial Transplant 24: 1071-1073 [Full Text]  
• Camm, A. J., Kirchhof, P., Lip, G. Y.H., Savelieva, I., Ernst, S. (2009). CHAPTER 29 Atrial Fibrillation. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]